Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-31 Sale |
2023-02-02 1:04 pm |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
1,636 | $10.12 | $16,556 | 79,707 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 1:02 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,900 | $10.12 | $19,228 | 193,227 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-02 4:31 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
258 | $11.85 | $3,057 | 24,450 (Direct) |
View |
| 2022-08-31 Sale |
2022-09-02 11:40 am |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
3,606 | $7.21 | $25,999 | 20,510 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-25 3:25 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
259 | $7.81 | $2,023 | 24,708 (Direct) |
View |
| 2022-04-30 Sale |
2022-05-03 5:19 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
254 | $6.62 | $1,681 | 24,967 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:35 pm |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
414 | $7.58 | $3,138 | 46,616 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:34 pm |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
331 | $7.58 | $2,509 | 44,082 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:33 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,374 | $7.58 | $10,415 | 45,285 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:32 pm |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
8,195 | $7.58 | $62,118 | 490,025 (Direct) |
View |
| 2022-01-26 Sale |
2022-01-28 4:29 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
111 | $8.09 | $898 | 22,095 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-07 08:38 am |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
46,968 | $9.15 | $429,757 | 298,220 (Direct) |
View |
| 2021-11-30 Sale |
2021-12-02 1:16 pm |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
3,803 | $12.03 | $45,750 | 23,697 (Direct) |
View |
| 2021-11-30 Sale |
2021-12-02 1:15 pm |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
2,587 | $12.03 | $31,122 | 14,913 (Direct) |
View |
| 2021-11-18 Purchase |
2021-11-19 3:05 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
160 | $13.1 | $2,096 | 21,997 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-02 3:45 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
258 | $17.16 | $4,427 | 24,337 (Direct) |
View |
| 2021-10-27 Sale |
2021-10-28 2:04 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
107 | $16.32 | $1,746 | 21,804 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-03 7:07 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
243 | $15.64 | $3,801 | 24,494 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-08 Option Award |
2023-06-09 3:26 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-06 Exercise(A) |
2023-02-28 12:29 pm |
2015-09-01 2022-09-01 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
1,030 | $0 | 1,434,958 (Indirect) |
View |
| 2022-06-06 Exercise(A) |
2023-02-28 12:29 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
1,030 | $5 | 1,434,958 (Indirect) |
View |
| 2022-10-21 Exercise(A) |
2023-02-28 12:23 pm |
2018-12-27 2022-12-27 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
47,999 | $0 | 1,485,168 (Indirect) |
View |
| 2022-10-21 Exercise(A) |
2023-02-28 12:23 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
47,999 | $5.94 | 1,485,168 (Indirect) |
View |
| 2022-06-16 Exercise |
2023-02-28 12:21 pm |
2015-09-01 2022-09-01 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
2,211 | $0 | 1,437,169 (Indirect) |
View |
| 2022-06-16 Exercise |
2023-02-28 12:21 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
2,211 | $5 | 1,437,169 (Indirect) |
View |
| 2023-01-31 Exercise |
2023-02-02 3:40 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
18,333 | $0 | 640,025 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 3:40 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
300,000 | $0 | 640,025 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 1:05 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-01-31 Exercise |
2023-02-02 1:04 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
3,333 | $0 | 79,707 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 1:04 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
60,000 | $0 | 79,707 (Direct) |
View |
| 2023-01-31 Exercise |
2023-02-02 1:02 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
3,833 | $0 | 193,227 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 1:02 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
40,000 | $0 | 193,227 (Direct) |
View |
| 2023-01-20 Exercise |
2023-01-23 7:10 pm |
2019-01-20 2023-01-20 |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
122,677 | $0 | 146,627 (Direct) |
View |
| 2023-01-20 Exercise |
2023-01-23 7:10 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
122,677 | $5 | 146,627 (Direct) |
View |
| 2022-11-08 Option Award |
2022-11-09 5:57 pm |
N/A 2032-11-08 |
UroGen Pharma Ltd. | URGN | Wildman Daniel George Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-10-31 Exercise |
2022-11-02 4:31 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
500 | $0 | 24,450 (Direct) |
View |
| 2022-10-21 Exercise |
2022-10-25 4:57 pm |
2018-12-27 2022-12-27 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
47,999 | $0 | 1,481,927 (Indirect) |
View |
| 2022-10-21 Exercise |
2022-10-25 4:57 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
47,999 | $5.94 | 1,481,927 (Indirect) |
View |
| 2022-09-14 Exercise |
2022-09-16 3:13 pm |
2019-10-07 2022-10-07 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
160,000 | $0 | 408,693 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-16 3:13 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
160,000 | $5 | 408,693 (Direct) |
View |
| 2022-09-08 Option Award |
2022-09-12 08:28 am |
N/A 2032-09-08 |
UroGen Pharma Ltd. | URGN | WEN LEANA Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-08-31 Exercise |
2022-09-02 11:40 am |
2015-09-01 2022-09-01 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $0 | 248,693 (Direct) |
View |
| 2022-08-31 Exercise |
2022-09-02 11:40 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $5 | 248,693 (Direct) |
View |
| 2022-08-31 Exercise |
2022-09-02 11:40 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
8,333 | $0 | 20,510 (Direct) |
View |
| 2022-06-06 Exercise |
2022-08-25 3:25 pm |
2015-09-01 2022-08-31 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
1,030 | $0 | 1,433,928 (Indirect) |
View |
| 2022-06-06 Exercise |
2022-08-25 3:25 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
1,030 | $5 | 1,433,928 (Indirect) |
View |
| 2022-07-31 Exercise |
2022-08-25 3:25 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
500 | $0 | 24,708 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 3:37 pm |
N/A 2032-06-08 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 3:37 pm |
N/A 2032-06-08 |
UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 3:37 pm |
N/A 2032-06-08 |
UroGen Pharma Ltd. | URGN | Cohen Fred E Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 3:36 pm |
N/A 2032-06-08 |
UroGen Pharma Ltd. | URGN | Holden Stuart Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 3:36 pm |
N/A 2032-06-08 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
10,000 | $0 | 10,000 (Indirect) |
View |
| 2022-04-30 Exercise |
2022-05-03 5:19 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
500 | $0 | 24,967 (Direct) |
View |
| 2022-03-25 Option Award |
2022-03-29 7:14 pm |
N/A 2032-03-24 |
UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2022-03-29 7:11 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer |
0 | $0 | 41,920 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 4:35 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
833 | $0 | 46,616 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:35 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
37,500 | $0 | 46,616 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 4:34 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
666 | $0 | 44,082 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:34 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
37,500 | $0 | 44,082 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 4:33 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
2,500 | $0 | 45,285 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:33 pm |
N/A 2032-01-31 |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
16,064 | $0 | 45,285 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 4:32 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
18,333 | $0 | 490,025 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:32 pm |
N/A 2032-01-31 |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
150,000 | $0 | 490,025 (Direct) |
View |
| 2022-01-26 Exercise |
2022-01-28 4:29 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
209 | $0 | 22,095 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-07 08:38 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
105,689 | $0 | 298,220 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 1:16 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
8,333 | $0 | 23,697 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 1:15 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
5,000 | $0 | 14,913 (Direct) |
View |
| 2021-10-31 Exercise |
2021-11-02 3:45 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
500 | $0 | 24,337 (Direct) |
View |
| 2021-10-26 Exercise |
2021-10-28 2:04 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
208 | $0 | 21,804 (Direct) |
View |
| 2021-07-31 Exercise |
2021-08-03 7:07 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
500 | $0 | 24,494 (Direct) |
View |